Aedes aegypti cells (A. aegypti cells)

Aedes aegypti cells refer to various cell lines, such as Aag2, derived from the yellow fever mosquito, which is the primary vector for human viral pathogens including Dengue, Zika, and Yellow Fever [1]. These cells are not a discrete molecular target like a receptor or enzyme; instead, they serve as a critical biological model system for studying mosquito-host-virus interactions and innate immune responses, particularly the RNA interference (RNAi) pathway [2]. In drug discovery and public health, these cell lines are utilized for high-throughput screening of antiviral compounds and the evaluation of insecticide efficacy [3]. While the mosquito itself is the focus of vector control strategies involving chemicals like pyrethroids that target the voltage-gated sodium channel, the designation 'Aedes aegypti cells' is considered too broad and non-specific to be classified as a singular therapeutic target [4]. Their primary value lies in providing a physiological context for understanding how arboviruses replicate and evade the insect immune system [5]. Citations: [1] World Health Organization, 'Mosquito-borne diseases'; [2] Journal of General Virology, 'The Aag2 cell line: a model for Aedes aegypti innate immunity'; [3] NIH, 'Cell-based assays for insecticide screening'; [4] PubMed, 'Molecular mechanisms of insecticide resistance in Aedes aegypti'; [5] Nature Communications, 'Viral suppression of RNAi in mosquito cells'.

Other names

Aag2 cellsYellow fever mosquito cellsAe. aegypti cell linesMosquito cells

N/A - This refers to a biological system/cell line rather than a single molecular target. Insecticides targeting these cells often act on the voltage-gated sodium channel or acetylcholinesterase.